Top Globe News – Lifestyle
Author:
Jaguar Health, Inc.
FDA Feedback Supports Extension Phase for Jaguar Health’s Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
March 18, 2026
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
March 11, 2026
←
Previous Page
1
2